Kovack Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Kovack Advisors, Inc.

$887 Million
Q2 2024

A detailed history of Kovack Advisors, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kovack Advisors, Inc. holds 332 shares of REGN stock, worth $349,011. This represents 0.04% of its overall portfolio holdings.

Number of Shares

332

Previous 332 -0.0%

Holding current value

$349,011

Previous $319,000 9.09%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$775.18 - $881.7 $2,325 - $2,645	-3 Reduced 0.9%	332 $291,000
Q3 2023 Oct 19, 2023	BUY	$692.45 - $844.37 $4,154 - $5,066	6 Added 1.82%	335 $275,000
Q2 2023 Jul 21, 2023	SELL	$700.03 - $830.35 $35,701 - $42,347	-51 Reduced 13.42%	329 $236,000
Q1 2023 Apr 20, 2023	BUY	$680.49 - $826.97 $37,426 - $45,483	55 Added 16.92%	380 $312,000
Q4 2022 Feb 22, 2023	SELL	$705.89 - $766.39 $7,058 - $7,663	-10 Reduced 2.99%	325 $234,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $458,602 - $578,731	-799 Reduced 70.46%	335 $231,000
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $285,690 - $384,935	-521 Reduced 31.48%	1,134 $670,000
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $167,823 - $196,957	282 Added 20.54%	1,655 $1.16 Million
Q4 2021 Jan 18, 2022	SELL	$543.48 - $670.97 $58,695 - $72,464	-108 Reduced 7.29%	1,373 $867,000
Q3 2021 Nov 03, 2021	BUY	$574.03 - $680.96 $623,396 - $739,522	1,086 Added 274.94%	1,481 $896,000
Q2 2021 Jul 29, 2021	BUY	$472.8 - $558.54 $186,756 - $220,623	395 New	395 $221,000
Q3 2020 Nov 02, 2020	SELL	$544.75 - $658.21 $198,833 - $240,246	-365 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$493.32 - $643.92 $180,061 - $235,030	365 New	365 $228,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $166,577 - $230,639	-556 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$372.08 - $439.57 $206,876 - $244,400	556 New	556 $228,000
Q4 2018 Feb 06, 2019	SELL	$335.82 - $403.04 $171,604 - $205,953	-511 Closed	0 $0
Q3 2018 Oct 09, 2018	SELL	$351.14 - $408.51 $80,762 - $93,957	-230 Reduced 31.04%	511 $206,000
Q2 2018 Aug 01, 2018	SELL	$284.6 - $344.99 $72,573 - $87,972	-255 Reduced 25.6%	741 $256,000
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $62,848 - $78,362	199 Added 24.97%	996 $343,000
Q4 2017 May 15, 2018	SELL	$358.63 - $469.95 $8,965 - $11,748	-25 Reduced 3.04%	797 $300,000
Q4 2017 Feb 01, 2018	SELL	$358.63 - $469.95 $105,795 - $138,635	-295 Reduced 26.41%	822 $309,000
Q3 2017 Aug 02, 2018	BUY	$431.38 - $504.0 $8,627 - $10,080	20 Added 1.82%	1,117 $499,000
Q2 2017 Aug 30, 2018	SELL	N/A	-1,279 Reduced 53.83%	1,097 $539,000
Q1 2017 Sep 05, 2018	BUY	N/A	1,424 Added 149.58%	2,376 $921,000
Q4 2016 Sep 10, 2018	BUY	N/A	952	952 $349,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Account

Kovack Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History